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ENHANCEMENT OF THE ABSCOPAL EFFECT IN RADIOTHERAPY BY IN-SITU 
DELIVERED CD40 ANTIBODY: PANCREATIC ADENOCARCINOMA MODEL 
 
Sayeda Yasmin-Karim, MBBS, PhD1, Michele Moreau, MSc1,2, Wilfred Ngwa, PhD,1,2 
1Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, 
Boston, MA; 2University Massachusetts Lowell 
 
Metastasis is the cause of death in most cancers. It has been observed by Mole and others that 
radiotherapy at one site may lead to regression of metastatic cancer at other sites, which were 
not irradiated, this phenomenon is called ‘abscopal’ effect.  Unfortunately, this regression is not 
predictable.  
 
Few studies observed some enhancement by systemic application of immunoadjuvants, which 
also has limited application because of generalized adverse effect. The purpose of this study is 
to evaluate the enhancing and abscopal effect of radiotherapy by in-situ delivered anti-CD40 in 
the treatment of pancreatic cancer.  
 
A syngeneic mouse model of pancreatic adenocarcinoma was generated in C57/BL6 
background mouse using Panc02 cell lines in both flanks. The palpable sized tumors of left 
flanks were treated as four different randomized cohorts: control with no treatment, direct 
treatment with 5 Gy of radiation, intra tumor treatment with CD40 antibody, and in combination. 
Tumor growth was measured on both sides.  
 
Result shows that in-situ application of CD40 antibody significantly enhances the effect of 
radiotherapy. Reduction of tumor volume was observed in both sides. The treated tumors (left) 
show average of 75% reduction of tumor volume by combination treatment compare to 32% 
reduction by radiation alone.   On the untreated side (right), it was 86% reduction with 
combination treatment compare to 20% reduction with the radiation alone which may be 
reminiscent of an abscopal effect. This result shows potential for translational studies to 
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